ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,Y
3,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4,1,Acute fatty liver of pregnancy,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
4,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
5,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6,2,Infantile apnoea,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
6,3,Neonatal hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
7,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
8,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
9,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
